Position in MDXH
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$209,475
+$72,317 QoQ
Shares Held
509,674
+754.7% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 26 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,695,016,013 across 33 Diagnostics & Research names. MDXH ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
574,992 | $288,277,988 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
1,193,601 | $270,696,770 | |
| 3 | GH |
Guardant Health, Inc.
|
1,449,534 | $217,473,585 | |
| 4 | DHR |
Danaher Corp /De/
|
943,694 | $179,754,833 | |
| 5 | RVTY |
Revvity, Inc.
|
1,457,335 | $162,143,091 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,101,501 | $146,312,377 | |
| 7 | NTRA |
Natera, Inc.
|
265,607 | $72,099,020 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
865,462 | $59,413,965 |
All Filings in MDXH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,475 | 509,674 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $137,158 | 59,634 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $339,549 | 95,112 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $227,561 | 48,938 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $82,835 | 37,482 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $70,166 | 29,606 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $145,453 | 69,930 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||